Search for: "MYERS v. STATE"
Results 381 - 400
of 1,538
Sort by Relevance
|
Sort by Date
4 Apr 2019, 8:11 pm
The Case of McCall v. [read post]
2 Apr 2019, 6:53 am
Bakov v. [read post]
29 Mar 2019, 8:32 am
Additional Resources: Schutz v. [read post]
20 Mar 2019, 7:51 am
Myers failed to provide reasonable assistance to Mr. [read post]
18 Mar 2019, 5:52 pm
District Court Judge Donald Molloy held today, in Myers v. [read post]
13 Mar 2019, 2:55 am
” (quoting Myers v. [read post]
12 Mar 2019, 5:50 pm
The record is not searched for an alternative basis to affirm.In Myers v. [read post]
11 Mar 2019, 1:03 pm
Supreme Court established limitations on personal jurisdiction over non-resident corporate defendants in state court “mass” actions in Bristol-Myers Squibb Co. v. [read post]
11 Mar 2019, 10:15 am
Co. v. [read post]
8 Mar 2019, 9:49 am
Serving West Palm Beach, Miami, Tampa, Orlando and Fort Myers/ Naples. [read post]
5 Mar 2019, 7:27 am
The Third Circuit joined with the Second Circuit in Myers v. [read post]
12 Feb 2019, 7:56 pm
Momenta Pharma v. [read post]
7 Feb 2019, 5:36 pm
In Momenta Pharmaceuticals, Inc. v. [read post]
6 Feb 2019, 7:30 pm
Brewer and Gagnon v. [read post]
6 Feb 2019, 6:12 am
| The IP term (thus far) of the millennium: the curious story of the adoption of "patent troll" and "internet trolling" | No pain, no gain: Plausibility in Warner-Lambert v Actavis | Testing the boundaries of subjectivity: Infringement of Swiss-type claims in Warner-Lambert v Actavis | Is SPINNING generic? [read post]
28 Jan 2019, 2:16 pm
Fogelson (2005) Making Civil Rights Law: Thurgood Marshall and the Supreme Court, 1936-1961 by Mark V. [read post]
22 Jan 2019, 2:09 am
One case, Bristol-Myers Squibb Co. v. [read post]
14 Jan 2019, 12:51 pm
Allen Myers LP v. [read post]
11 Jan 2019, 11:14 am
The Court stated that “in so holding, we are persuaded by our prior precedent and the Second Circuit’s well-reasoned decision in [Myers v. [read post]
4 Jan 2019, 9:16 pm
On December 5, 2018, the General Court ruled in favor of the European Commission in an action brought by Bristol-Myers Squibb Pharma (BMS) against the Commission and the European Medicines Agency (EMA) in the case, T‑329/16, read here. [read post]